| Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | Lancet, The | 2020 | 25.2K |
| Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | Lancet, The | 2020 | 15K |
| A novel coronavirus outbreak of global health concern | Lancet, The | 2020 | 3.7K |
| Detection of SARS-CoV-2 in Different Types of Clinical Specimens | JAMA - Journal of the American Medical Association | 2020 | 2.8K |
| Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial | Lancet, The | 2020 | 2.1K |
| Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed | Lancet Psychiatry,the | 2020 | 1.6K |
| Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia | Journal of Thrombosis and Haemostasis | 2020 | 1K |
| Viral load of SARS-CoV-2 in clinical samples | Lancet Infectious Diseases, The | 2020 | 1K |
| Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2 | Circulation Research | 2020 | 1K |
| Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) | Clinical Infectious Diseases | 2020 | 986 |
| Gender Differences in Patients With COVID-19: Focus on Severity and Mortality | Frontiers in Public Health | 2020 | 982 |
| A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2 | Nature | 2020 | 844 |
| Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study | European Respiratory Journal | 2020 | 820 |
| Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells | Cell | 2020 | 806 |
| Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia | Clinical Chemistry | 2020 | 794 |
| A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 | Science | 2020 | 682 |
| Mental Health and Psychosocial Problems of Medical Health Workers during the COVID-19 Epidemic in China | Psychotherapy and Psychosomatics | 2020 | 649 |
| Transplantation of ACE2 Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia | | 2020 | 644 |
| Characteristics of COVID-19 infection in Beijing | Journal of Infection | 2020 | 637 |
| Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study | Chinese Medical Journal | 2020 | 619 |
| Broad and strong memory CD4 and CD8 T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 | Nature Immunology | 2020 | 615 |
| The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study | The Lancet Global Health | 2020 | 576 |
| Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients | Cell Host and Microbe | 2020 | 528 |
| Ferroptosis: past, present and future | Cell Death and Disease | 2020 | 508 |
| Progression of Mental Health Services during the COVID-19 Outbreak in China | International Journal of Biological Sciences | 2020 | 479 |
